Top 10 recent developments in health-related quality of life in patients with systemic lupus erythematosus topical collection on systemic lupus erythematosus

Anisha Bharadwaj Dua, Zahi Touma, Sergio Toloza, Meenakshi Jolly*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that has major implications for health-related quality of life (HRQoL). Improvements in the monitoring and management of SLE improves survival; however, improvement of HRQoL remains of paramount importance among these patients. Measurement of HRQoL has been recommended in clinical practice and research including drug development and testing in clinical trials. Both generic and disease specific instruments have been developed to ascertain HRQoL. In an increasingly global collaborative environment, the importance of assessing HRQoL across nations, acknowledgment of their confounders, and limitations of used instruments are critical. Here, we review selected major developments in the past 5 years highlighting: the importance of measuring HRQoL in SLE patients, the benefits and limitations of instruments that exist, and their application in research settings.

Original languageEnglish (US)
Article number380
JournalCurrent rheumatology reports
Volume15
Issue number12
DOIs
StatePublished - Dec 2013

Keywords

  • Clinical trials
  • Confounders
  • Health-related quality of life
  • Modifiers
  • Patient-reported outcomes
  • QoL
  • Quality of life
  • Systemic lupus erythematosus

ASJC Scopus subject areas

  • Rheumatology

Fingerprint Dive into the research topics of 'Top 10 recent developments in health-related quality of life in patients with systemic lupus erythematosus topical collection on systemic lupus erythematosus'. Together they form a unique fingerprint.

Cite this